An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-20
DOI
10.3389/fimmu.2021.680435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting hypoxic tumor microenvironment in pancreatic cancer
- (2021) Jinxin Tao et al. Journal of Hematology & Oncology
- Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner
- (2021) Hongzhen Li et al. Clinical Epigenetics
- Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
- (2021) Rong Liu et al. Frontiers in Oncology
- A four-chemokine signature is associated with a T cell-inflamed phenotype in primary and metastatic pancreatic cancer
- (2020) Joan Miguel Romero et al. CLINICAL CANCER RESEARCH
- Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
- (2020) Raefa Abou Khouzam et al. SEMINARS IN CANCER BIOLOGY
- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- Hypoxia activated prodrug evofosfamide treatment in pancreatic ductal adenocarcinoma xenografts alters the tumor redox status to potentiate radiotherapy.
- (2020) Shun Kishimoto et al. ANTIOXIDANTS & REDOX SIGNALING
- The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis
- (2020) Adile Orhan et al. EUROPEAN JOURNAL OF CANCER
- Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis
- (2020) Ashutosh Tiwari et al. GASTROENTEROLOGY
- Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
- (2020) Zhuomao Mo et al. Frontiers in Genetics
- Resolving the HIF paradox in pancreatic cancer
- (2020) Natividad R. Fuentes et al. CANCER LETTERS
- Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
- (2020) Dajia Liu et al. Biomedicines
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
- (2019) Ashton A. Connor et al. CANCER CELL
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer
- (2019) Tara N. Fujimoto et al. CANCER RESEARCH
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
- (2019) Paul C. McDonald et al. GASTROENTEROLOGY
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
- (2019) Zheng-Lin Ou et al. RNA Biology
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
- (2018) Kimio Yonesaka et al. CLINICAL CANCER RESEARCH
- The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis
- (2018) He-Li Gao et al. Hepatobiliary & Pancreatic Diseases International
- TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
- (2018) Jinfeng Xiang et al. Cell Death & Disease
- Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
- (2018) Andrew J. Rech et al. Cancer Immunology Research
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
- (2018) Lingjian Yang et al. EBioMedicine
- Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
- (2018) Kentaro Inamura et al. Journal of Clinical Medicine
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model
- (2017) Carla Hajj et al. Translational Oncology
- B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells
- (2017) Dongbao Li et al. Oncotarget
- T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
- (2017) Ingunn M. Stromnes et al. Cancer Immunology Research
- Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
- (2017) Sacha Gnjatic et al. Journal for ImmunoTherapy of Cancer
- Hypoxia induces TWIST-activated epithelial–mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice
- (2016) Shi Chen et al. CANCER LETTERS
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
- (2016) Ines Lohse et al. Oncotarget
- Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
- (2016) Esko A. Kautto et al. Oncotarget
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Hypoxia-mediated immune evasion of pancreatic carcinoma cells
- (2015) YEBIN LU et al. Molecular Medicine Reports
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
- (2015) K. E. Lee et al. Cancer Discovery
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
- (2014) Long-Yun Ye et al. PANCREATOLOGY
- Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
- (2014) Ines Lohse et al. Cancers
- PanIN-Specific Regulation of Wnt Signaling by HIF2 during Early Pancreatic Tumorigenesis
- (2013) A. Criscimanna et al. CANCER RESEARCH
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma
- (2013) XIN ZHAO et al. Oncology Letters
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- B7-H3 overexpression in pancreatic cancer promotes tumor progression
- (2012) XIN ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
- (2011) Q. Chang et al. CANCER RESEARCH
- Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide
- (2011) I. B. Barsoum et al. CANCER RESEARCH
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now